Paxlovid, Pfizer's new antiviral medication "may currently be under-prescribed to high-risk people and over-prescribed to low-risk people." CP3 Director Dr. Walid Gellad told Stat. Though the White House began encouraging doctors to prescribe Paxlovid more, there have been concerns about viral resistance to the drug and worry that it has not been prescribed to the right patients. The article was reprinted by PBS Newshour.